FIGURE 4.

Cross‐validation of the target network mechanism. This independent validation was performed on schizophrenia (a) and healthy participants (b). The schizophrenia patients received real continuous theta‐burst magnetic stimulation (cTBS) treatment over the temporo‐parietal junction for 2 weeks and showed significant symptom alleviation. Two groups of healthy participants were randomly assigned to receive real or sham cTBS over the supplementary motor area for 5 days. The second real group was used to test the reproducibility of the findings. The target network was defined as the regions showing significant functional connectivity with the target area (p < .0001). The absolute connectivity strength of the target network significantly decreased in all of the real groups, and no change was found in the sham group. *p < .05, **p < .01, ***p < .001